Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
Public ClinicalTrials.gov record NCT02949388. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed as a randomized, double blind, parallel group, placebo-controlled trial to study the efficacy and safety of two oral doses of Prurisol administered twice daily for twelve weeks to subjects with moderate to severe chronic plaque psoriasis.
Study identification
- NCT ID
- NCT02949388
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 199 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2016 (Actual)
- Primary completion
- Nov 2017 (Actual)
- Completion
- Dec 2017 (Actual)
- Last update posted
- Feb 13, 2018
2016 – 2017
United States locations
- U.S. sites
- 34
- U.S. states
- 20
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Study Site | Glendale | Arizona | 85308 | — |
| Study Center | Hot Springs | Arkansas | 71913 | — |
| Clinical Study Site | Rogers | Arkansas | 72758 | — |
| Study Center | Los Angeles | California | 90017 | — |
| Study Site | Los Angeles | California | 90036 | — |
| Clinical Study Site | Murrieta | California | 92562 | — |
| Clinical Study Site | Oceanside | California | 92056 | — |
| Study Site | Sherman Oaks | California | 91403 | — |
| Study Site | Denver | Colorado | 80209 | — |
| Clinical Study Site | Denver | Colorado | 80210 | — |
| Study Site | Port Orange | Florida | 32127 | — |
| Clinical Study Site | Tampa | Florida | 33609 | — |
| Study Site | Savannah | Georgia | 31406 | — |
| Study Center | Arlington Heights | Illinois | 60005 | — |
| Clinical Study Site | South Bend | Indiana | 46617 | — |
| Study Center | Overland Park | Kansas | 66215 | — |
| Study Site | Louisville | Kentucky | 40217 | — |
| Clinical Study Site | Clarkston | Michigan | 48346 | — |
| Clinical Study Site | Clinton Township | Michigan | 48038 | — |
| Clinical Study Site | St Louis | Missouri | 63117 | — |
| Study Site | Las Vegas | Nevada | 89106 | — |
| Clinical Study Site | Portsmouth | New Hampshire | 03801 | — |
| Clinical Study Site | Berlin | New Jersey | 08009 | — |
| Clinical Study Site | New York | New York | 10012 | — |
| Clinical Study Site | Portland | Oregon | 97210 | — |
| Study Site | Johnston | Rhode Island | 02919 | — |
| Study Center | Austin | Texas | 78759 | — |
| Clinical Study Site | Houston | Texas | 77004 | — |
| Clinical Study Site | Pflugerville | Texas | 78660 | — |
| Clinical Study Site | San Antonio | Texas | 78213 | — |
| Clinical Study Site | San Antonio | Texas | 78229 | — |
| Study Site | San Antonio | Texas | 78229 | — |
| Study Site | Webster | Texas | 77598 | — |
| Study Center | Charlottesville | Virginia | 22911 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02949388, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 13, 2018 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02949388 live on ClinicalTrials.gov.